So-Young International Inc ADR(SY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.34 | Insider Own | 9.54% | Shs Outstand | 85.0M | Perf Week | -12.11% |
| Market Cap | 0.19B | Forward P/E | - | EPS next Y | 85.45% | Insider Trans | - | Shs Float | 76.9M | Perf Month | -18.18% |
| Enterprise Value | 0.14B | PEG | - | EPS next Q | -0.05 | Inst Own | 9.78% | Short Float | 1.28% | Perf Quarter | 22.95% |
| Income | -0.03B | P/S | 0.75 | EPS this Y | 50.02% | Inst Trans | -4.98% | Short Ratio | 1.88 | Perf Half Y | -22.41% |
| Sales | 0.26B | P/B | 1.05 | EPS next 5Y | - | ROA | -9.09% | Short Interest | 0.99M | Perf YTD | -12.11% |
| Book/sh | 2.14 | P/C | 1.53 | EPS past 3/5Y | -54.33% - | ROE | -15.18% | 52W High | -52.63% ($4.75) | Perf Year | -26.95% |
| Cash/sh | 1.47 | P/FCF | - | Sales past 3/5Y | 4.3% 2.47% | ROIC | -14.35% | 52W Low | 75.78% ($1.28) | Perf 3Y | 172.67% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 61.28% | Gross Margin | 44.35% | Volatility(W/M) | 5.33% 4.96% | Perf 5Y | -44.46% |
| Dividend TTM | - | EV/Sales | 0.54 | Sales Y/Y TTM | 30.18% | Oper. Margin | -15.44% | ATR (14) | 0.14 | Perf 10Y | - |
| Dividend Ex-Date | 2025/4/8 | Quick Ratio | 1.33 | EPS Q/Q | 32.93% | Profit Margin | -13.6% | RSI (14) | 34.06 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.61 | Sales Q/Q | 41.75% | SMA20 | -13.31% ($2.6) | Beta | 2.15 | Target Price | $7.3 |
| Payout | - | Debt/Eq | 0.26 | Earnings | 2026/8/31 | SMA50 | -11.75% ($2.55) | Rel Volume | 0.19 | Prev Close | $2.27 |
| Employees | 2348 | LT Debt/Eq | 0.13 | EPS/Sales Surpr. | 51.3% 5.92% | SMA200 | -11.41% ($2.54) | Avg Volume(3M) | 0.52M | Price | $2.25 |
| IPO | 2019/5/2 | Option/Short | Yes/Yes | Trades | 409 | Volume | 98,477 | Change | -0.88% |
💠 So Young International is a company that operates a consumption healthcare and beauty platform in China. Starting out as an online information and booking platform, the company has recently expanded its business focus by running its own beauty centers that offer non-invasive and minimally invasive procedures. It connects consumers with a variety of aesthetic medical services, including thread lifts, light- and ultrasound-based treatments, and hyaluronic acid and botulinum toxin (Botox) injectable procedures.
Over the past 1 year, roughly in the middle
53% below its 1-year high.
Traded less than usual. That is 19% of its average volume.
SY has a sound balance sheet but weak earning power
Of every $100 in sales, $15.44 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +50.0% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $75. Peers typically go for $75.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -44.5%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 9.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #26 of 41 in the industry
Based on market cap of $191M.
SPOK#24 Spok Holdings Inc $218M PER 18.0 
AMWL#25 American Well Corp $210M PER - SY#26 So-Young International Inc ADR $191M PER - 
OPRX#27 OptimizeRx Corp $165M PER 37.2 
HCAT#28 Health Catalyst Inc $129M PER - 
FAQ
What kind of company is SY?
SY belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of SY?
The market cap of SY is approximately $191M, ranking 4,062 within its sector.
What is the 52-week high and low for SY?
SY has recorded a 52-week high of $4.75 and a low of $1.28.
